Evolution of MUC1 During Retrotransposon Expansion as a Potential Adaptation Exploited in Human Cancer

Area of Science:

• Genetics and Evolutionary Biology
• Immunology
• Cancer Biology

Background:

• The MUCIN 1 (MUC1) gene and its encoded protein, MUC1-C (M1C), evolved in placental mammals alongside endogenous retroviruses (ERVs).
• MUC1-C plays a role in protecting epithelial barriers and its activation influences the STAT1 and type I interferon (IFN-I) pathway.

Purpose of the Study:

• To explore the role of MUC1-C in regulating retrotransposon expression, including human ERVs (HERVs), LINE-1 (L1), and Alu elements.
• To understand how M1C signaling integrates retrotransposon activity with the induction of APOBEC3 genes.
• To investigate the dual role of M1C in promoting anti-tumor immunity via viral mimicry and facilitating cancer cell immune evasion.

Main Methods:

• Literature review and synthesis of existing research on MUC1, retrotransposons, and the immune system.
• Analysis of MUC1-C's regulatory mechanisms involving STAT1 and the IFN-I pathway.
• Examination of the interplay between retrotransposon activation, viral mimicry, and immune responses in cancer.

Main Results:

• MUC1-C regulates HERV expression through a STAT1-dependent mechanism.
• M1C signaling integrates retrotransposon transcription with the induction of APOBEC3 genes, which also emerged in placental mammals.
• Retrotransposon activation triggers a viral mimicry response via IFN-I, promoting innate anti-tumor immunity, while M1C sustains IFN-I induction for cancer cell immune evasion.

Conclusions:

• MUC1-C-dependent regulation of retrotransposons and APOBEC3 genes is an adaptive mechanism exploited by cancer cells.
• This regulation contributes to malignant progression by balancing anti-tumor immunity induction and immune evasion.
• The findings highlight a complex interplay between host defense mechanisms and cancer cell adaptation involving endogenous retroelements.